share

3-(2,3,4-Trimethyl-6-Oxo-2,6-Dihydro-7H-Pyrazolo[3,4-B]Pyridin-7-Yl)Propanoic Acid CAS NO 1018126-46-9


Unit Price:

CAS No.:1018126-46-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3-(2,3,4-Trimethyl-6-Oxo-2,6-Dihydro-7H-Pyrazolo[3,4-B]Pyridin-7-Yl)Propanoic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for the research and development of novel therapeutic agents, particularly in oncology and other specialized drug discovery programs. It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers requiring a reliable supply of high-quality building blocks for complex synthesis.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly for targeted cancer therapies.
  • Drug Discovery & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization in research pipelines.
  • Biochemical Research: Serves as a precursor or reference standard in biochemical assays and proteomics research.
  • Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis and scale-up projects.
  • Academic Research: Utilized in university and institutional labs for advanced organic synthesis and heterocyclic chemistry studies.

Basic Information

Product Name 3-(2,3,4-Trimethyl-6-Oxo-2,6-Dihydro-7H-Pyrazolo[3,4-B]Pyridin-7-Yl)Propanoic Acid
CAS No. 1018126-46-9
Molecular Formula C14H17N3O3
Molecular Weight 275.30 g/mol
Synonyms 7H-Pyrazolo[3,4-b]pyridine-7-propanoic acid, 2,3,4-trimethyl-6-oxo-2,6-dihydro-; 3-(2,3,4-Trimethyl-6-oxo-1,6-dihydro-7H-pyrazolo[3,4-b]pyridin-7-yl)propanoic acid; 1018126-46-9; Trimethyl-oxo-dihydro-pyrazolopyridine-propanoic acid; Pyrazolopyridine propanoic acid derivative; Advanced heterocyclic intermediate; Pharmaceutical building block CAS 1018126-46-9
EINECS Contact for details

Quality Control

Our 3-(2,3,4-Trimethyl-6-Oxo-2,6-Dihydro-7H-Pyrazolo[3,4-B]Pyridin-7-Yl)Propanoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and MS, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with complete analytical data are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC) Conforms to reference standard
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.